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ABSTRACT 
Background 
Multi-compartment compliance aids (MCAs) are repackaging systems for solid 
dosage form medicines, heralded by some as a solution to non-adherence but 
with little evidence of benefit.  
Objective 
To use a theoretical approach to describe the behavioural determinants impacting 
the use of MCAs in older people from the perspectives of the individual and health 
and social care providers.  
Design 
A case study investigation. 
Setting 
Three very sheltered housing sites in North-East Scotland. 
Subjects 
Twenty residents (≥65 years) using an MCA for at least six months and 34 
members of their care team (17 formal carers, 8 general practitioners (GPs), 8 
pharmacists, one family member).  
Methods 
Semi-structured, face to face interviews with items based on the Theoretical 
Domains Framework. Interviews were audio-recorded, transcribed and analysed 
thematically.  
Results 
Several behavioural determinants impacted the use of MCAs from the 
perspectives of the stakeholders involved. Goals of use related to promoting 
adherence and safety, with less emphasis on independence. Beliefs of 
consequences related to these goals and were considered of value, with additional 
consequences of concern around reduced awareness of medicines and 
complexities of changing medicines. There was a lack of clearly defined roles of 
professionals for all processes of MCA use, with evidence of blurring and gaps in 
roles. There were additional issues relating to capabilities of older people in using 
MCAs and capacity issues for pharmacy supplied MCAs. 
Conclusions 
Several behavioural determinants impacted the use of MCAs and while MCAs were 
valued, there is a need to more clearly define, develop, implement and evaluate a 
model of care encompassing resident and medicines assessment, supply and 
ongoing review of MCAs.  
 
Key points 
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1. Several behavioural determinants impacted the use of MCAs in older people 
within very sheltered housing  
2. While valued, there were concerns of reduced awareness of medicines and 
complexities of changing medicines  
3. There was a lack of clearly defined roles in all MCA processes, issues of 
capabilities of older people and pharmacy capacity. 
 
Keywords 
Multi-compartment compliance aids; older people; sheltered housing; case study; 
behaviours  
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1. INTRODUCTION 
In 2009, the Scottish Government developed a strategy for improving the quality 
and outcomes of current models of care for older people to ensure that they are 
valued as an ‘asset’, that their voices are heard and that they are supported to 
enjoy full and positive lives in their own home or homely setting [1]. Giving voice 
to the individual is congruent with community care legislation which has at its 
core the ‘ability of individuals to articulate their own needs’ [2]. This emphasis on 
inclusion is integral to the personalisation agenda [3] where ‘people become more 
involved in how services are designed and receive the support that is most suited 
to them’ [4]. More recently the focus for the support of older people has been 
based on themes of enablement to assist them to ‘either learn or re-learn those 
skills needed for a successful and fulfilling life’ [5].  
 
Enablement, appropriate support and articulation of need are of direct relevance 
to the management of medicines. Given the prevalence of multimorbidity [6,7] 
and the emphasis on evidence based therapeutics, older people are likely to be 
prescribed multiple medicines. Recent United Kingdom data highlighted that 
20.8% of those with two clinical conditions were prescribed four to nine 
medicines, and 1.1% of patients ten or more medicines [8]. Promoting 
appropriate polypharmacy (defined as appropriate prescribing of many 
medicines) [9] through concordant models of care should be a key goal in older 
people.  
 
Overprescribing has serious consequences of increasing the likelihood of adverse 
drug reactions and hospitalisation [10,11]. Medicines adherence, defined as ‘the 
process by which patients take their medicines as prescribed, composed of 
initiation, implementation and discontinuation’ [12], may also be impacted. 
Medicines adherence is a ‘complex multidimensional behaviour’ [13], with non-
adherence estimated to be prevalent in 47% to 100% of older people [14].  Key 
factors related to unintentional non-adherence are complex medicines regimens, 
poor memory and cognition [15].  
 
Multi-compartment compliance aids (MCAs) are repackaging systems for solid 
dosage form medication, which are removed from manufacturer’s original 
packaging and repackaged into the MCA [16]. While these are heralded by some 
as a solution to non-adherence, the Royal Pharmaceutical Society of Great Britain 
has stated that pharmacy supplied MCAs have ‘become regarded as a panacea for 
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medicines use and often integrated into practice and service policy without giving 
due consideration to the alternatives’ [16].  
 
Despite their use, there is scant evidence that MCAs improve medicines 
adherence or lead to greater involvement in decision making [17-19]. Nunney et 
al. reported a qualitative study of older people living independently in the 
community and an unrelated sample of health professionals involved in the 
supply of MCAs [20]. Key findings were that maintaining independence and 
control over medicines was important but that MCAs were often initiated without 
any systematic assessment. To date, no published studies have employed a case 
study approach to study MCA use in a targeted population of older people. 
Furthermore, there is notable absence of any theoretically based studies hence 
insufficient understanding of the behavioural determinants of MCA use.  
 
The aim of this research was to use a theoretical approach to describe the 
behavioural determinants impacting the use of MCAs in older people resident in 
very sheltered housing from the perspectives of older people, their families and 
health and social care providers.  
 
2. METHOD 
2.1 Design 
This was a case study investigation, described as a ‘wrapper for different 
methods’ [21] or a means with which ‘to explain present 
circumstances…[through]…in-depth description of social phenomenon’ [22]. The 
case study approach seeks to understand a phenomenon (MCA use) in-depth 
through empirically gathered data.  
 
2.2 Inclusion and exclusion criteria 
Multiple case studies were conducted in North-East Scotland focusing on residents 
of very sheltered housing (VSH) aged 65 years or over who had been using an 
MCA for at least six months. Sheltered housing is a United Kingdom term 
covering a wide range of rented housing for older and/or disabled or other 
vulnerable people. VSH generally has all the features of sheltered housing, but 
has a greater level of care and support offered through the service of extra 
wardens, full-time carers, assistance with everyday living and the provision of 
meals [23]. Potential participants were identified by the VSH senior carer who 
also screened and excluded residents with significant cognitive or welfare issues.  
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2.3 Recruitment 
The primary care lead pharmacist (who was known to the VSH senior carer) 
invited verbally each of the screened residents to take part in a face-to-face, 
audio-recorded, semi-structured interview of approximately 15 minutes duration. 
The content of the study information leaflet was discussed and their questions 
answered before informed, signed consent was taken and the interview arranged 
for a time convenient to the participant.  
 
2.4 Data generation 
Interviews, which were conducted by a senior researcher with extensive 
experience in qualitative interviewing and iterative techniques, took place either 
within the resident’s home or a quiet space within the VSH. Residents 
participating were asked to name people in their care team involved in any aspect 
of MCA use who could also be interviewed for this research. They were prompted 
by the researcher with suggestions of formal carers within the VSH, their general 
practitioner (GP), pharmacist, family and friends or others. The researcher 
contacted all of the identified individuals, with no exclusions, provided information 
and invited their informed consent prior to arranging a time convenient to them 
for a face-to-face or telephone interview of approximately 15 minutes duration. 
 
2.5 Interview schedule 
The questions in the semi-structured interview schedules were developed from 
the Theoretical Domains Framework (TDF) which includes constructs from 33 
behaviour change theories, and proposes that determinants of behaviour are 
clustered into 14 domains of: goals; beliefs about consequences; intentions; 
professional role and identity; knowledge; beliefs about capabilities; 
environmental context and resources; skills; optimism; reinforcement; memory, 
attention and deficit processes; social influences; emotions; and behavioural 
regulation [24,25]. Use of this framework ensured that a wide range of 
theoretical explanations for behaviour were considered. Two interview schedules 
were collectively developed by the research team: one for residents; one for the 
others. Each interview schedule was reviewed independently for credibility by an 
expert panel four individuals with expertise in health services research and use of 
the TDF.   
 
The schedule for the resident focused on: when and why an MCA was first 
introduced; who was involved in making that decision; how the MCA was used 
and any difficulties encountered; perceptions of benefit; and any monitoring or 
7 
review undertaken. The schedule for the care team was similar, with additional 
coverage of: any resident or medicines assessment undertaken prior to 
introducing the MCA; perceptions of the roles of other members of the care team 
in MCA use; and general comments on the use of MCAs in older people.  
 
2.6 Data handling 
Audio-recordings were transcribed verbatim and checked for transcribing 
accuracy by a member of the research team. Members of the research team met 
to agree consistency of the initial coding framework. Transcripts were analysed 
independently by three researchers using the Framework Approach following the 
five steps of: data familiarisation; identifying constructs; indexing; charting; 
mapping; and interpreting [26].  
 
2.7 Ethical approval 
This study had formal approval from the NHS North of Scotland Research Ethical 
Review Service (14/NW/1168) and NHS Grampian Research & Development 
Committee (2014RG002). 
 
3. RESULTS 
Twenty interviews were conducted with residents at three sites (A,B,C). All of the 
residents were aged 65 and over, and 15 were female. Further interviews were 
conducted with people in the residents’ care team which included: formal carers 
(17), GPs (8), pharmacists (8) and one family member.  
 
Key themes are described in relation to TDF domains. 
 
3.1. Goals of MCA use 
While carers, GPs and pharmacists described a number of the goals they hoped to 
achieve by using MCAs, residents were generally less aware of the goals. 
 
3.1a. Adherence  
One goal cited by many was to promote medicines adherence, particularly given 
the number of medicines residents were likely to be prescribed and their potential 
physical and cognitive issues.  
 
“To help bring some rationality and repetitive drug taking that is the chaos 
of most people's multiple pharmacy.” (GP 1 at C) 
 
8 
“Just to make it easier for people to handle their medicines, be it if they've 
got memory problems or too many medicines for them to cope with...hand 
issues...sight problems also.” (Pharmacist 1 at C) 
 
“It's a weekly dosage system, an aide memoire to the person to tell them 
what time of the day their medications due, what pill they're supposed to 
take at that time.” (Carer 2 at C) 
 
3.1b. Safety 
Promoting safe use of medicines was also a goal, cited largely by carers. 
Residents were described as being at potential harm due to the number and types 
of medicines, and that these were reduced through MCA use,  
 
“The safety of the resident as well, I think, if they've got loads of 
medications then it's easier just to have it in the one little thing instead of 
spread out…” (Carer 1 at B) 
 
 
 
3.1c. Independence 
Fewer interviewees described goals related to promoting resident independence, 
described in the context of both medicines adherence and promoting resident 
safety,  
 
“…it keeps people independent for longer I think. Sometimes if you're just 
able to work it out and make it a bit simpler for them they're able to stay 
at home and not do themselves any harm.” (GP 1 at A) 
 
3.2. Beliefs of consequences of MCA use 
Several of the beliefs of consequences of using MCAs were also closely related to 
the goals of adherence and safety.  
 
3.2a. Adherence 
Many interviewees, including several residents, noted the enhanced adherence,  
 
“Well they make certain that people who might not have full 
comprehension don't take their tablets at the wrong time and in the wrong 
sequence.” (Resident 3 at B) 
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3.2b. Safety 
Carers, GPs and pharmacists described MCA use resulting in reduced potential for 
harm, particularly in vulnerable residents,  
 
 “It's somebody else's life you're dealing with and some people are on an 
antipsychotic medication, so you've got to be very careful what you're 
doing, so it's definitely a good idea.” (Carer 4 at A) 
 
“Quicker and easier for them…and various issues around patient safety…” 
(Pharmacist 2 at B) 
 
“I think it can take away the stress…it can be a safer way of doing it.” 
(GP2 at A) 
 
3.2c. Independence 
While few had mentioned independence as a goal of using MCAs, several viewed 
that enhanced resident independence was a consequence,  
“It's about the tenants taking ownership of the medication as well and 
realising that… it's giving them ownership as well and responsibility.” 
(Carer 2 at A) 
 
Several additional themes emerged, which had not been described in relation to 
the purpose or goals of using MCAs. 
 
3.2d. Patient centred care 
Several carers believed as a result of the MCA, time was released for them to 
devote to person centred care. They described that prior to the MCA, they spent 
much more time assisting the residents with their medicines rather than focusing 
on the residents themselves,  
 
“ I think it's giving us more time with them and that is I think the benefit 
of having a blister pack [MCA] is that you're nae [not] having to, 'faff 
about' with loads of other bottles…and give them your time” (Carer 1 at C) 
 
3.2e. Reduced awareness 
One negative consequence was the reduced awareness of the medicines being 
taken and their indications, described by residents, carers and GPs,  
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“I don't know what tablets look like to be honest, because I don't see 
them…I try to describe them when the patient has them…” (GP 1 at B) 
 
“Sometimes we're not 100% aware what the tablets are for...” (Carer 1 at 
C) 
 
“…I think one is especially at night for sleeping. The other ones is just, I 
think, vitamins.” (Resident 5 at A) 
 
3.2f. Changes to medicines 
One consequence which was a major concern was the complexities and 
associated workload around managing changes in residents’ medicines, 
particularly when this occurred part way through the MCA cycle. This issue was 
described at length by carers, GPs, pharmacists and some residents,  
 
“Yeah, so you can't identify them. I've seen us getting a phone call to say 
that a certain tablet has been stopped. Can you remove it from the blister 
pack [MCA] ? It's a little white tablet, well she's got 3 or 4 of those...” 
(Carer 1 at B) 
 
“If we go and say 'let’s stop this one', and even, if you change it on the 
computer but don't actually manage to tell the pharmacist, it can lead to 
problems because they're not aware…” (GP 2 at A) 
 
“At one point, it was like 4, 5 changes a week, so you're talking about 20 
boxes are getting redone.” (Pharmacist 2 at C) 
 
3.3. Intention to use MCAs  
Several GPs were of the opinion that there was a need to increase the use of 
MCAs in older people,  
 
 “…most people over 75 should probably, would probably benefit from a lot 
of their medicines being in a Dosette [MCA]. It almost should be maybe an 
opt out rather than an opt in.” (GP 1 at C) 
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3.4. Social and professional roles relating to MCA use 
Residents, carers, GPs and pharmacists all described a range of views and 
experiences regarding their role in the commencement, supply and use of MCAs. 
It was clear that there were great variations in practice and very little 
standardisation.  
 
3.4a. Assessment process 
In terms of assessing whether or not a resident would be suitable for an MCA, a 
very mixed picture emerged as to whose role it was,  
 
“Well, the patient, the family and myself probably.” (GP 1 at C) 
 
“And that was discussed with the GP and when they [my parents] came 
here it was decided...” (Relative of Resident 5 at B) 
 
“Generally, they mostly come from the doctor… and nurses, they've had 
quite a bit of input recently as well, a few of the district nurses.” 
(Pharmacist 1 at C) 
 
One pharmacist described situations where MCAs had been commenced on the 
instruction of GPs without any systematic assessment resulting in the residents 
being provided with MCAs that they were unable to use,  
 
“we've started 3 that we didn't assess on the doc [doctor’s instructions], 
because we were told...you know, they don't need assessed and then they 
haven't been able to use it.” (Pharmacist 3 at A) 
 
One pharmacist expressed concern over the lack of resident involvement in 
making the decision to commence an MCA,  
 
“But I think we need to be having a bit of two way dialogue and discussing 
things, getting the patient involved in the decision as well so it's not 
completely taking that decision away from them.” (Pharmacist 1 at A) 
 
While there was no systematic approach, one pharmacist described how it could 
operate in practice, focusing on the multidisciplinary team and the resident,  
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“I think it should be multidisciplinary, it should really be initial assessment 
to see how they're managing…I think generally should be an approach 
from a family member and then maybe on to the GP, possibly a health 
care visitor or a nurse maybe go out and assess it, depending on what 
level of needs they have.” (Pharmacist 2 at C) 
 
3.4b. Reviewing medicines  
The review of medicines, as part of the assessment process was uncertain; where 
it was performed, it was rather opportunistic, 
 
“What medications they're on, yeah. So I think in terms of the blister pack 
[MCA] review, that's usually pharmacists, relatives, carers, that sort of 
thing or a GP opportunistically.” (GP 2 at A) 
 
“So the patient prescription would get ordered by the pharmacy, doctor 
would just see the request and they'd just sign it.” (Pharmacist 2 at C) 
 
3.4c. Preparation of the MCA 
While there was general agreement that preparing the MCA was the remit of 
pharmacy, it was less clear who should negotiate this with the pharmacy,  
 
“Well the way I usually play it is to say to the patient or the relative it's up 
to them to negotiate with the pharmacy if they'll agree to do it because 
obviously, obviously, it's a time element for the pharmacist.” (GP 3 at B) 
 
3.4d. Monitoring  
Very little emphasis was placed on the role of monitoring the benefits, or 
otherwise, or the need to continue the MCA,   
 
“…so I guess opportunistically, when you go in to do a house call you can 
often tell. Sometimes when the pharmacies go in to deliver, it if they find 
there's maybe three unopened ones in someone’s house or relatives see 
that people are not opening their blister packs [MCAs], we get feedback 
that way.” (GP 2 at A) 
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3.5. Knowledge impacting MCA use 
While there was little discussion of knowledge, several GPs noted that they had 
no awareness of any alternatives to assist residents with managing their 
medicines,   
 
“It's hard to know when you don't know what the alternatives are, never 
worked with alternatives, it's hard to think what they are.” (GP 1 at B) 
 
3.6. Beliefs of capabilities in using MCAs  
3.6a. Dexterity 
Many residents, carers, GPs and pharmacists described that using an MCA was 
not always easy for residents or carers and that a high level of manual dexterity 
was required,   
 
“I would say sometimes, I’ve, you've got a really little one [tablet] and it 
sticks in the corner...You've to watch that you get that one, you know.” 
(Resident 1 at C) 
 
“I've lost a few little eins [ones], dropped on the floor, ken [know] like 
that thyroid tablets, their teeny [tiny]…They're awful little, if you drop one 
it's always picked up, know what I mean, they're dirty.” (Resident 4 at A) 
 
“it's sometimes quite difficult, they may all come out at once and may end 
up on the floor.” (GP 4 at A) 
 
3.6b. Confusion 
One carer also described situations where residents had taken the wrong 
medicine at the wrong time,  
 
“… some have inadvertently popped morning when it should have been 
night and vice versa.” (Carer 2 at C) 
 
3.7. Environmental context and resources impacting MCA use 
Several themes emerged in relation to environment and resources which 
influenced MCA use.  
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3.7a. Capacity 
Capacity within pharmacies to cope with the demands for MCAs and the resultant 
workload was a major concern for pharmacists,  
 
“I mean it's something I deal with every day of my life, every minute of 
the day really. There's always a phone call about Dosette boxes [MCAs]…” 
(Pharmacist 3 at A) 
 
While some GPs were aware of the issue they did not understand fully the 
implications,  
 
“As far as I'm aware most pharmacies just have a capacity issue with the 
number they can do. What those issues are around that I don't really 
know but, I guess it's probably quite time consuming to put together…” 
(GP 3 at A) 
 
3.7b. Remuneration 
Pharmacists did not feel that the current remuneration system was appropriate in 
terms of rewarding the time and risk involved and did not encourage them to 
adopt a more clinical role,  
 
“To my mind it doesn't satisfactorily reimburse for the amount of time that 
goes into the process and it doesn't, it doesn't let us, kind of, let us do 
what we should be doing which is kind of reviewing patients before they 
start on the system to make sure the right people are on…” (Pharmacist 1 
at A) 
 
4.DISCUSSION 
This research employed a theoretical approach to extend the evidence base 
around MCA use in older people. Key findings are that several behavioural 
determinants impact the use of MCAs from the perspectives of the stakeholders 
involved. Goals of use related to the perceived value of MCAs in promoting 
adherence and safety, with less emphasis on independence. While these were 
linked to the beliefs of the consequences of use, there were additional 
consequences which are of concern; reduced awareness of medicines and 
complexities of changing medicines. There was a lack of clearly defined 
professional and social roles in all processes of MCA use, issues relating to 
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capabilities of older people to use MCAs and capacity issues for pharmacy 
supplied MCAs. 
 
Steps were taken to promote research trustworthiness (e.g. expert review of the 
interview schedules, triangulation of the perspectives of the residents and 
members of the care team and iterative questioning) which enhanced the 
credibility and dependability of the findings [27]. There are, however, some 
limitations hence the findings should be interpreted with caution. The research 
was undertaken in North-East Scotland in VSH residents without significant 
cognitive or welfare issues thus the findings may not be transferable to other 
populations or health systems. Despite this limitation, some of the findings (e.g. 
MCAs often initiated without systematic assessment) are similar to that of 
Nunney et al. [20] in a study conducted in England in older community dwelling 
people. 
 
Our case study based research generated data from multiple sources and 
perspectives. Older people being valued as assets, articulating their own needs, 
being involved in service design, staying in homely settings and enablement are 
core to the Scottish Government ‘2020 Vision’ and associated agendas [1-5]. 
While MCAs are valued and may support medicines management in older people, 
through the articulated goals of adherence, safety and independence, the findings 
indicate that there are key issues from the perspective of residents, carers, GPs 
and pharmacists which require to be addressed.  
 
The use of the theoretical framework (TDF) has allowed greater understanding of 
the determinants of MCA use and the different perspectives of those involved. 
Issues of medicines management generally and non-adherence specifically are 
likely to be prevalent in older people in VSH settings and MCAs are often seen as 
solutions [3]. This was evident from this research in that promoting adherence 
and patient safety were cited as goals which impacted the decision to commence 
MCAs. However, there was little clarity over who was or should be involved in 
that decision or the factors considered. The processes of patient assessment for 
suitability, review of medicines, communication within the health and social care 
team and with the resident, supply of the MCA and review of any benefit in 
relation to the goals seemed uncertain, blurred and often absent. However, all 
interviewees expressed views in relation to their beliefs of the consequences of 
MCAs, indicating that these were considered to be valuable in resident care. 
These positive consequences centred on adherence, safety and independence 
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with negative consequences around managing changes in medicines, reduced 
awareness of medicines and perhaps reduced resident independence. However, it 
was evident that there was a lack of alternatives so starting an MCA was 
perceived to be the only option. 
 
While MCAs were valued, there is a need to more clearly define, develop, 
implement and evaluate a model of care relating to MCAs. This is warranted given 
the demographic change of the population hence the likely increasing demand for 
pharmacy supplied MCAs, as described by several interviewees. One benefit of 
the theoretical focus of this research is that specific behavioural determinants can 
be linked to change strategies and indeed evidence suggests that TDF-based 
interviews may encourage respondents to identify barriers that they would not 
otherwise disclose [28]. Cane et al. have aligned behaviour change techniques  
mapped to TDF behavioural determinants as an aid to characterising and 
designing behaviour change interventions [29]. For example, while information 
provision via education and training may be relevant to change knowledge and 
skills, altering beliefs of consequences may require persuasive communication 
and monitoring the consequences of one’s own behaviour. Changing aspects of 
the professional role and identity and the environmental context and resources 
will be much more complex involving remodeling of health and social care 
structures and processes. Another theoretical framework worthy of consideration 
in remodeling is  
 
Further research should now focus on a larger scale study to confirm the key 
determinants before developing, implementing and evaluating a model of care to 
meet defined and agreed goals. The model of care should encompass: the 
identification of individuals who may benefit from an MCA; review of the 
medicines; assessment of capability to use an MCA; issues relating to supply; and 
review of benefit. Given the lack of published evidence in this area, the first stage 
of development should involve all the key stakeholders (particularly older people 
and their carers) using a consensus based approach. 
 
In conclusion, this study has identified that several behavioural determinants 
impact the use of MCAs in older people within VSH and that while these are 
valued, there is a need to more clearly define, develop, implement and evaluate 
the model of care.  
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